The novel therapy of the medication represents a exciting breakthrough in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide108560.blogsuperapp.com/42567340/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment